Last reviewed · How we verify

NCT00304382

Humoral Determinants of Immunity to Pneumococcal Infection

Completed Phase 4 Last updated 5 September 2017
What this trial tests

Phase 4 trial testing Prevnar in Pneumonia in 114 participants. Completed in 1 June 2012.

Timeline
1 January 2003
Primary endpoint
1 September 2006
1 June 2012

Quick facts

Lead sponsorVA Office of Research and Development
PhasePhase 4
StatusCompleted
Study typeINTERVENTIONAL
Allocationrandomized
Designcrossover
Maskingnone
Primary purposeprevention
Enrollment114
Start date1 January 2003
Primary completion1 September 2006
Estimated completion1 June 2012
Sites1 location across United States

Drugs / interventions tested

Conditions studied

Sponsor

VA Office of Research and Development — full company profile →

Who can join

Eligibility, any sex, with Pneumonia or Pneumococcal Infections. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The purpose of this study is to determine whether there are differences in the level of antibody to capsular polysaccharides of S. pneumoniae or the physiological activity of such antibody after vaccinating patients who have recovered from pneumococcal pneumonia with pneumococcal polysaccharide vaccine (Pneumovax) or conjugate pneumococcal vaccine (Prevnar).

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other trials of Prevnar

Trials testing the same drug.

Other recruiting trials for Pneumonia

Currently open trials in the same condition.

Other VA Office of Research and Development trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT00304382.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing